跳至主要内容
临床试验/NCT03449277
NCT03449277Unknown4 期

Oral Nifedipine Versus Labetalol in Treatment of Postpartum Hypertension

Hossam Ahmed Abd Ellah1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年1月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
100
试验地点
1
主要终点
control blood pressure

研究概览

简要总结

Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy research has focused on the antenatal complications' for both mother and baby and the risks and benefits of administering antihypertensive therapy prior to delivery hypertension disorders of pregnancy often persist following delivery and sometimes arise de novo postpartum one of the maternal complications of pre eclampsia is residual chronic hypertension in about 1/3 of cases elevated blood pressure is seen in 6%to 8% of all pregnancies hypertension (arterial pressure >140/90 mmhg) in pregnancy is classified into one of four conditions

  1. chronic hypertension that precedes pregnancy
  2. pre eclampsia and eclampsia: a systematic syndrome of elevated arterial pressure,proteinuria and other findings
  3. pre eclampsia superimposed upon chronic hypertension
  4. gestational hypertension or nonproteinuric hypertension of pregnancy

详细描述

Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy research has focused on the antenatal complications' for both mother and baby and the risks and benefits of administering antihypertensive therapy prior to delivery hypertension disorders of pregnancy often persist following delivery and sometimes arise de novo postpartum one of the maternal complications of pre eclampsia is residual chronic hypertension in about 1/3 of cases elevated blood pressure is seen in 6%to 8% of all pregnancies hypertension (arterial pressure >140/90 mmhg) in pregnancy is classified into one of four conditions

  1. chronic hypertension that precedes pregnancy
  2. pre eclampsia and eclampsia: a systematic syndrome of elevated arterial pressure,proteinuria and other findings
  3. pre eclampsia superimposed upon chronic hypertension
  4. gestational hypertension or nonproteinuric hypertension of pregnancy evaluate the effectiveness, safety and acceptability of Oral nifedipine versus oral labetalol in treatment of persistent postpartum hypertension

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women who have hypertension during pregnancy and persist after delivery till discharge of hospital about 2 days of monitoring the blood pressure

排除标准

  • Women with history of secondary hypertension Women with eclampsia who need intensive care unit admission and indicated other drugs rather than oral nifedipine and oral labetalol Women who have any contraindication to Nifedipine or labetalol

研究组 & 干预措施

take oral nifedipine tablets

Active Comparator

Women who take the oral tablets of nifedipine till discharge of hospital

干预措施: Oral Tablet (Drug)

take oral labetalol tablets

Active Comparator

Women who take the oral tablets of labetalol till discharge of hospital

干预措施: Oral Tablet (Drug)

结局指标

主要结局

control blood pressure

时间窗: till discharge of hospital about two days

duration,total dose to achieve blood pressure below the critical value between 140 and 150 mmHg systolic and 90-100 mmHg diastolic by monitoring of blood pressure

次要结局

  • Improvement of hematological values(till discharge of hospital about two days)
  • Side effects in both groups(till discharge of hospital about two days)
  • Improvement of other investigations(till discharge of hospital about two days)
  • Resolution of complications(till discharge of hospital about two days)

研究者

发起方
Hossam Ahmed Abd Ellah
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hossam Ahmed Abd Ellah

Principal investigator

Assiut University

研究点 (1)

Loading locations...

相似试验

Oral Nifedipine Versus Labetalol in Treatment of... | 临床试验